Trimetazidine Dihydrochloride IP 35 mg  Modified Release Tablet

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet

181.0 INR/Strip

Product Details:

  • Salt Composition Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet
  • Dosage Form Tablet
  • Pacakaging (Quantity Per Box) 10x10 tablet
  • Indication Trimetazidine Dihydrochloride IP 35mg is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
  • Ingredients Azathioprine (25 mg).
  • Physical Form Tablets
  • Dosage 35 mg
  • Click to View more
X

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet Price And Quantity

  • 181.0 INR/Strip
  • 100 Strip

Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet Product Specifications

  • Tablets
  • Trimetazidine Dihydrochloride IP 35mg is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
  • Azathioprine (25 mg).
  • 35 mg
  • Tablet
  • 10x10 tablet
  • Trimetazidine Dihydrochloride IP 35 mg Modified Release Tablet
  • Use as directed by a healthcare professional

Product Description

Description

  • Each Film Coated Modified Release Tablet Contains: Trimetazidine Dihydrochloride IP 35 mg

Doses

  • As Directed by Physician

Indication

Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Cardic Care Medicine' category



We accept minimum 10 boxes of all products.
Back to top